All News

Hard to keep up with all the good news. Congrats to @philseo, Program Director extraordinaire and Director of the Johns Hopkins Vasculitis Clinic, for receiving the ACR Distinguished Clinician Scholar Award. #ACR21 @HopkinsMedicine @HopkinsMedNews https://t.co/FQb2W6KpYT
Max 🦖 MaxKonigMD ( View Tweet)
8M415 Gout Imaging Advances: Ralf Thiele on US🔊and DECT US>DECT: DECT needs a minimal density of MSU; DCS, tophi <2mm, liquid tophi may not be detected; US can show hyperemia DECT>US: DECT can show areas that may be overlooked from standard protocols 💡Bonus:stay around for Q&A https://t.co/G7yQaj9fHw
USSONAR USSONAR_Rh ( View Tweet)
🔥Continued, More Clinically Meaningful data in #SSc #ILD from #Nintedanib in >52 wk SENSCIS & SENSCIS-ON(open-label ext)#ACR21 Dr Distler ✨MMF likely to stay 1st line, then Nintedanib ❓Is it time for MMF + Antifibrotic upfront?? Await SLS-III;Data so far seems supportive https://t.co/JWXMlsJgmc
Ashima Makol MD AshimaMakol ( View Tweet)
Great Q&A re:VEXAS w/Marcela Ferrada When to suspect VEXAS? Male, MCV >100, Plt <200 Can you order genetics yourself? No. 😆 Any IMT that works? Require high dose steroid, partial response to TCZ, needs close f/u d/t possible neutropenia! How to refer to NIH? Slide!!! ⬇️⬇️ https://t.co/UvUCFbvX2r
Mike Putman EBRheum ( View Tweet)
Tribute #RheumPix to a special time in San Fran for ACR 2015 w/ my dear Father,Dr. Kamal M. El Ramahi, MD, FACR -may he Rest in Peace. I was an IM Res then not yet settled on a specialty when he sweetly invited me...the Rheum seed began its blossom #ACR21 https://t.co/cp4eFCbTWl https://t.co/ayKAPi0WA2

Links:

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
A study at #ACR21 by Charite-University Medicine Berlin researchers suggests taking tumor necrosis factor inhibitor (TNFi) #biologics earlier in the course of disease could slow down spinal progression in #AxialSpondyloarthritis patients. https://t.co/lDkaMkOcez
CreakyJoints.org CreakyJoints ( View Tweet)
#ACR21 - I don't remember the final count from ACR20, but 23k tweets🐦and 78.6 Million🔥 impressions have to be some type of record. @rheum_cat with over 1,600 tweets and counting. Don't forget the 𝐀𝐂𝐑𝟐𝟏 𝐓𝐰𝐞𝐞𝐭 𝐔𝐩 (𝟖𝐌𝟓𝟐𝟎) today at 6:00 PM. https://t.co/8qEMiorQCo
Steven Echard, CAE StevenEchard ( View Tweet)
Join us now at the #ACR21 #COVID19 community hub to hear Kevin Winthrop and @RADoctor discussing about vaccines in patients with RMDs #ACRAmbassador https://t.co/LivAoLu810
Alessia Alunno alessia_alunno ( View Tweet)
Alcohol and MTX don't go along! In a cohort of 1000+ early RA Factors associated w/ 1️⃣Nausea Female OR 2 🍺 Alcohol OR 1.44 DAS28CRP OR 1.16 2️⃣Alopecia Age OR 4.87 🍺 Alcohol OR 1.98 HAQ score OR 1.62 #Abst1444 #ACR21 @RheumNow https://t.co/zZG6aFR1SX
Aurelie Najm AurelieRheumo ( View Tweet)
👉HCQ dose < 400 mg/d are assc with SLE flare. Lower doses of HCQ may decrease risk of retinopathy. 👉For >80 kg (176 lbs), any dose < 400 mg/day is assc with increased odds of flare (HCQ blood levels not measured) Abst#1462 #ACR21 @rheumnow https://t.co/5tx3kruT8W
TheDaoIndex KDAO2011 ( View Tweet)
I will be at the Early Career community Hub in 5 minutes (at 5pm Eastern) with @DanielHSolomon discussing "How to Get Published" #ACR21

Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)

Dr. Furie thinks that pulse IV steroids are more effective than oral high dose steroids. If you use pulse IV, you can then use a lower oral dose of prednisone w/faster taper. Will he mandate pulse IV steroids w/his next trial? ...long pause.. No. #ACR21 @rheumnow

TheDaoIndex KDAO2011 ( View Tweet)

CBD for pain in hand OA/inactive PsA: - works in animal models (many things do) - other neg RCTs didn't use CBD itself - DBRCT: 12w continuous, n=136, min dropout Result: does absolutely nothing I bet big money it will be tried again & again @Joner_MD #ACR21 ABST1456 @RheumNow https://t.co/lZLVrgrKST
David Liew drdavidliew ( View Tweet)
Dr Vela presents DB RCT on cannabidiol in hand OA and PsA. No effect seen. Abstr#1456 #ACR21 @RheumNow https://t.co/ck2eUx5Elz
Richard Conway RichardPAConway ( View Tweet)
The opening of #ACR21 Convergence was a hit for all who signed up and viewed in. The day included the presidential address by outgoing president Dr. David Karp (UT Southwestern) and a keynote talk and interview with Dr. Seema Yasmin (Stanford). Read more.. https://t.co/m98lrjFgS4 https://t.co/vKpCEDJiyx

Links:

Dr. John Cush RheumNow ( View Tweet)
COVID in Rheumatologic Disease Patients: Drs. Sparks, Liew, Yazdany and Dao provide an update on data specific to COVID in rheumatologic disease patients. @jeffsparks @drdavidliew @KDAO2011 #ACR21 https://t.co/IzDIpe5IrU https://t.co/6i8C3Grw9q

Links:

Dr. John Cush RheumNow ( View Tweet)
apart from that, fibrosis is fascinating - as is the potential for a shared fibrotic pathway #ACR21 Antifibrotics session @RheumNow https://t.co/FXbhBx9sJ1
David Liew drdavidliew ( View Tweet)
@ericdeinmd Although the MTX/alopecia - nausea poster was interesting. Abst#1444 #ACR21 Factors assc w/MTX- nausea/alopecia: 👉female sex 👉EtOH use 👉higher disease activity 👉belief that the med will cause it (older age assc w/⬇️risk of nausea) https://t.co/XDKFhvN0V1 @rheumnow

Links:

TheDaoIndex KDAO2011 ( View Tweet)

#ACR21 Ab#1445. RTX & #covid19 outcomes ⭐️RTX ass. w/ Upwards arrow COVID hospitalization, ICU admission, and ventilation ▶️We need huge caution in pts that have not been vax'ed before RTX 💉💉 @Rheumnow https://t.co/6UNUVhnBkI https://t.co/vHkQe9fZpI

Links:

Eric Dein ericdeinmd ( View Tweet)
#ACR21 Ab#1036. Rheum is often the field of uncertainty. @zach_wallace_md shows uncertainty correlates w/ depression, anxiety, sickness impact across rheum diseases ⭐️Is uncertainty something to target as intervention? @Rheumnow https://t.co/v9kbk2hCqO https://t.co/50ELS3ZQp9

Links:

Eric Dein ericdeinmd ( View Tweet)
×